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After Captain James Cook’s discovery of the Sandwich Islands in
1778 and Captain George Vancouver’s visit in 1793, the Hawaiian
nation was devastated by foreign diseases to which it had no
immunity. During the time of the Discovery Era of the 1770’s,
scholars estimated the Hawaiian population to have been between
250,000 and 300,000. That number fell to 108,579 according to an
1835-1836 American missionary census. The population dropped
even further to 84,165 in a 1850 government census. In 1887 King
Kalakaua reported that the Hawaiian population of 400,000 had
been reduced to one-tenth its size.’ Gonorrhea and syphilis in their
most virulent forms were first introduced, resulting in severe
disabilities, infant deaths, infertility, and ocular complications.
Then measles, whooping cough, influenza, smallpox, cholera and
tuberculosis took their toll.
The earliest report of ophthalmological problems in Hawaii was
by a missionary physician Alonzo Chapin. He wrote in the 1830s,
“Ophthalmia of the purulent form, abounds in every portion of the
group [i.e., population], and opaque corneas and thickened coats of
the eyes, are very numerous.”2Missionary Mercy Whitney filled her
journal with references to “the ophthalmia.” On February 7, 1830,
she wrote “I have an attack of it almost every year of our residence
here.”3
In his 1954 work, Nine Doctors and God, Francis John Halford
describes how even physicians were not immune to ophthalmologi
cal problems. “In 1844 missionary physician James Smith of Koloa,
Kauai, complained of sore eyes, probably conjunctivitis, which so
many of the missionaries seemed to pick up within a short period of
time after landing, obviously a contagion from the Orient, where
ophthalmia is common and chronic.4 This affliction is usually
accompanied by a catarrhal condition of the nasal and bronchial
passages. It has been suggested that these symptoms are allergic
responses to the molds and pollens prevalent in the moist and humid
tropical atmosphere of the islands. Another possibility is trachoma,
a disease endemic in the Orient.”
Robert C. Schmitt’s thesis entitled “Two Centuries ofEye Care in
Hawaii,” was written with the collaboration of Ogden D. Pinkerton
MD, and published in the Hawaiian Journal of History in 1985.
Schmitt and Halford left the only substantial references to the
history of ophthalmology. Schmitt notes that the first person to sell
eyeglasses was E. H. Boardman, a maker of watches and chronom
eters. On September 9, 1846, Boardman advertised “gold, silver and
steel-framed spectacles and othergoods for sale.” Optometry emerged
as a separate discipline when “An Act to Regulate the Practice of
Optometry” was passed by the 1917 Territorial Legislature. The law
required all optometrists to have at least two years ofhigh school and
either three years of experience in a registered office or a degree
from a reputable school of optometry. The most famous eyeglass
seller was William “Doc” Hill, who was as an optician and optom
etrist. He was the first licensee under the newly passed Optometric
Act. He became involved with high-level financial circles and the
Hawaiian Legislature.
According to Schmitt, who depended on commercial journals for
reference, one of the earliest physicians specializing in eye disor
ders was Joseph Bechtinger, MD; a multilingual Austrian who
moved from Washington, DC to Honolulu in 1866. For six months,
beginning March 24, Bechtinger advertised his services, with “par
ticular attention paid to the Diseases of the eyes.” He sailed for Hong
King on March 2, 1867 and eight years later he advertised his Eye,
Ear, Nose and Throat Institute in San Francisco.
In 1872 a Hugo Stangenwald, MD offered to treat “patients
suffering from Chronic Diseases including the diseases of the Eye
and Ear, Throat and Lungs.” In 1880 Charles Neilson, MD adver
tised “Eye and Ear Cases successfully treated.” E. Pontoppidian,
MD, a 38-year-old German arrived in Honolulu on October 2, 1881
and described himself as an “Oculist, Physician, and Surgeon, Eye
Diseases a Specialty.” Three months later he discontinued his
newspaper notices and left the islands. In 1896 Dr H.C. Sloggett was
listed in the directory as a Honolulu “Eye and ear specialist,” and Dr
William L. Moore of Hilo as, “Makes a Specialty of Eye and Ear.”
From 1899 to 1905, the Honolulu Eye and Ear Infirmary was
operated first by Dr Sloggett and later by Dr Moore.
Dr William Gibson Rogers was the first Hawaii ophthalmologist
with authenticated credentials. He was born in Greenfield, Ohio, on
February 14, 1864, and received his medical degree from Pulte
Medical College in Cincinnati, Ohio, in 1891. From 1899 to 1900,
Dr Rogers took a special course at the Royal Ophthalmic and
Central London. He came to Honolulu in November, 1900 and
opened an office specializing in diseases of the eye, ear, nose and
throat. In 1904, Dr Rogers took a postgraduate course at the
Manhattan Eye, Ear, Nose and Throat Hospital in New York,
followed by additional specialty training at the Postgraduate Hospi
tal, New York, in Vienna in 1909 to 1910, and the Chicago
Polyclinic Hospital in 1916. From 1917 to 1918, Dr Rogers served
as eye, ear, nose and throat consultant for the Selective Service
medical advisory board. He retired in 1920 and died in Honolulu on
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September 29, 1936.
About the time that Dr Rogers retired, Dr. James A Morgan
arrived in Honolulu and opened his office at the Young Hotel
Building to practice eye, ear, nose and throat medicine (EENT). He
had trained at the renowned Philadelphia General Hospital.
Leprosy
Any history of ophthalmology in Hawaii must mention a disease
endemic in Hawaii—leprosy or Hansen’s disease. Leprosy, with its
inevitable ocular involvement before sulfone drugs, became a major
public health problem in the mid-nineteenth century. The Hawaii
Board of Health, established in 1850, founded a leper settlement at
Kalawao, Molokai in 1865 and moved it to Kalaupapa a few years
later. King Kamehameha V by direction of the Board of Health
mandated that all lepers be isolated from the general population. The
“Act to Prevent the Spread of Leprosy” authorized police officers,
and Board of Health agents to arrest and deliver alleged lepers for
medical inspection and for removal to a place of treatment or
isolation.6Poor nursing and medical care, lack of food, clothing, and
shelter, and absence of law and order for several decades turned this
banishment into the most inhumane edict in Hawaiian government
history.
Before the advent of sulfone drugs, in 1946 nothing could arrest
the disease. From 1920 to 1946, chaulmogra oil was injected
intramuscularly frequently causing renal damage. Presently, the
principal drugs for treatment of leprosy are dapsone (sulfone),
rifampin, clofazimine, ethionamides, corticosteroids. and atropine
for iridocyclitis. The Mycobacterium leprate can now be cultured in
the live nine-banded armadillo, a Dasypodidae.
Leprosy affects the eyes in several ways;: it damages the zygo
matic branch of the facial nerve, causing paralysis of the orbicularis
muscle, it damages the trigeminal and nasociliary nerves causing
loss of corneal sensitivity, conjunctivitis, keratitis, corneal ulcer
ation, iridocyclitis, and secondary glaucoma; it damages the sensory
nerve fibers of the cornea causing early photophobia and eventual
anesthesia. Iridocyclitis and uveitis are very common complica
tions.
From 1922 to 1948, DrF.J. Pinkerton regularly visited Kalaupapa
and provided surgical care for the ophthalmological problems.
Dr Robert T. Wong was the ophthalmological consultant from
1948 to 1992. He made monthly visits to Kalaupapa on a single-
engine plane, which made many hazardous landings. One of his last
patients before he retired in 1992 was from the Hansen’s Disease
Program.
Dr Donald Sort became the principal consultant to the program in
1972 and he served in the program until his death in 1996.
Advances in Ophthalmology
In 1941 Hawaii was just emerging from a decade of severe
economic depression. The population statistics were:
l940 19908
All Islands 422,770 1,108,229
Oahu 257,696 836,231
Honolulu 179,358 377,059
The gross state product was $309 million in 1940 compared to
$26,945 million in l990. Medical care, particularly ophthalmol
ogy, was of comparatively high quality, considering that Hawaii
was an agricultural community isolated from medical academic
centers. Kuakini Hospital was a small institution; St. Francis had
been founded just a decade earlier; Queen’s Hospital was our only
major hospital with a national reputation. There were no peer review
committees, but our notable Drs Nils P. Larson, Joseph Strode,
Harry Arnold, Sr, Rogers Hill, and F.J. Pinkerton were our leaders
who elevated the quality of medical care.
Since 1941, ophthalmology has seen more research and instru
ment development than in any other era. Electron microscopy has
unraveled histochemical secrets of the eye previously never imag
ined. Newer diagnostic tools include fluorescein angiography,
ultrasonography, electroretinography, computerized axial tomog
raphy, and radioactive phosphorous (P32). Therapy has been revolu
tionized by new antibiotics, corticosteroids, diuretics, antimetabo
lites, antifungal and antiviral agents, and antihypertension ocular
agents.
Innovations during the past 50 years include the use of alpha
chymotrypsin in cataract extraction, cryosurgery,
phacoemulsification and phacofragmentation of cataracts, implan
tation of intraocular lenses, refinement of suture materials and
needles, refractive surgery, retinal surgery and keratoplasty, laser
photocoagulation, and new techniques in tumor and vitreous sur
gery. In recent years, the operating microscope has enabled the
ophthalmic surgeon to perform operations with incredible accuracy
and precision.
Neuro-ophthalmology and neurosurgery were advanced by Ralph
Cloward. The influx of specialists began to restrict the surgical
privileges of general practitioners. The leaders in ophthalmology
were F.J. Pinkerton, Harold Moffat, Thomas Cowan, Robert H. Lee,
Sr., Wilfred Minatoya, and Robert T. Wong.
Cataract Surgery
In 1941, cataract surgery was done as follows: first a 170-degree
corneoscleral incision with the von Graefe knife; then a complete or
peripheral iridectomy; followed by pre-placement of corneoscleral
sutures; finally removal of the lens with the Kalt or Arruga lens
forceps Complications included injury to the iris with the cataract
knife, rupture of the lens capsule with the forceps, vitreous loss, and
wound separation. The Kalt needle with its fine point, round edge,
and insufficient rigidity made closure of the corneoscleral wound
difficult. Sharp, beveled, cutting-edge needles with adequate rigid
ity became available in 1942. Barraquer’s erisophake became
available in 1950, and the keratome replaced the von Graefe knife.
Shigemi Sugiki procured the first electrically powered cryoprobe
for lens delivery in 1965, and phacoemulsification became avail
able in 1971. Intraocular lens implantation, (without doubt the most
significant development in ocular surgery) began in 1972. The
pioneers of this procedure in Hawaii were Drs Percival Chee,
Wayne Wong, and Gerald Faulkner.
Intraocular Lens Implantation
In 1949 Ridley of London introduced a lens implant which was
unsuccessful because of the weight, inadequate fixation, and endot
helial and intraocular complications. In the 1 950s an anterior
chamber lens was devised. Even with internationally known sur
geons such as Strompoli, Danneheim, Choyce, Worst, and Barraquer
involved, the high incidence ofpost-operative complications nearly
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doomed intraocular lens implantation.
Enthusiasm for lens implantation was revived briefly
when lenses that depended on iris fixation were de
signed. But this proved physiologically unsound and
was abandoned. In December 1963 Binkhorst did an
extracapsular extraction and inserted an iris-clip lens
without the anterior loops. In 1968 Binkhorst and
Choyce ofLondon devised an improved lens implant of
polymethylmethacrylate. Binkhorst pioneered and dem
onstrated the advantages of extracapsular surgery with
a posterior chamber implant fixed with loops . The
incidence of corneal edema, endothelial damage, and
intraocular complications were reduced dramatically.
In Hawaii Gerald FaulknerMD introduced the Kelman
phacoemulsification machine in 1971. Next year Drs
Percival Chee and Wayne Wong successfully intro
duced the pupillary or iris-clip lens in a series of
patients. In 1973, Faulkner combined his extracapsular
extraction by phacoemulsification with the Binkhorst
posterior chamber implant. The popularity and success
of the posterior chamber lens has been dramatic in the
last two decades. The anterior chamber lens is still used
in special situations. The latest exciting development is
the foldable silicone implant and sutureless cataract
extraction.
Glaucoma Surgery
In 1941 considerable attention was given to acute
glaucoma and the pupillary block mechanism influ
enced by the techniques of Otto and Hans Barkan of
San Francisco. Nearly every ophthalmologist in Ha
waii possessed a Koeppe or Barkan lens gonioscope
and a portable Barkan binocular microscope. Curran,
as early as 1920, and Otto Barkan in 1938, began to
differentiate between open and closed angle glaucoma.
In 1941, acute angle closure glaucoma was called acute
congestive glaucoma, and the classical Graefe iridec
tomy was generally acknowledged as the only effective
operation.
Limited access to proper medical care resulted in a
high incidence of acute angle closure glaucomas pro
gressing to chronic angle closure glaucomas or chronic
congestive glaucomas. A limited number of basal in
dectomies were performed for this latter condition with
mostly unsatisfactory results. Inidosclerectomy of
LaGrange, or an iris inclusion operation, was the best
procedure.
Corneoscleral trephine was the operation of choice
for medically refractory open angle glaucomas. A few
preferred cyclodialysis. About 1950 Scheie’s
thermoscierec-tomy became the operation of choice
for both refractory open angle and chronic angle clo
sure glaucoma.
In 1968 John Cairns of England reported his results
with trabe-culectomy, the first effective and safe surgi
cal procedure for open angle glaucoma. ‘° The proce
dure creates an opening into the anterior chamberunder
a scleral flap. The opening is extended from the limbus
CHOH
CH3
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to, the scieral spur and parts of the cornea, trabeculae. and sciera are
removed. It is now the most popular surgery worldwide for glau
coma. Trabeculectomy is also the preferred procedure for uncon
trolled chronic primary angle closure glaucoma and for acute angle
closure glaucoma when iridectomy is considered inadequate. The
procedure was established in Hawaii in 1971 by Drs Herbert Pang,
Chee, Thomas Frissell, and Sugiki.
Trabeculectomy is the prime surgical procedure for medically
refractory open angle glaucoma. Laser trabeculoplasty on occasion
will circumvent trabeculectomy while Neo-YAG cyclophotoablation
is considered a last resort.
Retinal Surgery
In 1941, retinal separation, retinal holes and tears, and retinal
disinsertion were treated with the Walker di
athermy and micro-pins. Lack of proficiency
and inability to localize peripheral tears limited
the success of this procedure before develop
ment of the indirect ophthalmoscope and the
Goldmann contact lens in 1950. The scleral
buckle was first used in Hawaii by Herbert Pang
in 1962. Scleral buckling for repair of retinal
detachment (particularly when there is subretinal
fluid) and for retinal tears (when there is persis
tent vitreous traction), involves the creation of
an indentation of the sclera toward the vitreous.
This provides apposition of the sclera and the
detached retinal parts allowing healing of the
retinal tear without surgical entry into the globe.
Absorbable materials such as facia lata, human
donor sclera, and gelatin were used formerly,
but now, nonabsorbable materials such as sili
cone rubber and silicone sponge are used more
often. Cryotherapy or laser surgery is used in
the treatment of retinal tears when there is no
fluid accumulation. New techniques in vitreous
and macular surgery offer new hope. The ar
rival of retinal fellowship-trained Drs Donald
Sroat, Worldster Lee, John Drouilhet, Gregg
Kokame, Pierre Pang, Byron Wong and Vernon
Wong has elevated the status of retinal surgery
in Hawaii to the level of academic centers.
Corneal and Refractive Surgery
Dr Thomas Frissell performed the first suc
cessful corneal transplant in 1956. The first-
fellowship-trained cornea specialist, Dr Gilbert
Yamamoto, arrived in 1979. With the help of the
late Dr Kent Bennett at Straub, Yamamoto
transformed the Makana Foundation tissue pro
curement system into today’s Hawaii Lions
Eyebank (which is sponsored and funded by the
District 50 Hawaii Lions Club). The Eyebank
can now network with mainland tissue banks
and process local tissue for distribution. Ap
proximately 120 to 140 keratoplasties are per
formed each year. As of 1995, 1,300 corneal
transplants have been performed since the in-
ception of the Eyebank in 1980. Now there are several more
fellowship-trained cornea specialists in Hawaii, viz Lloyd Minaai,
Rhodes Stevens, Steven Gee, and John Olkowsky. With the advent
of high technology refractive centers, patients can seek PRK
(photorefractive keratectomy), ALK (automated lamellar kerato
plasty), PTK (phototherapeutic keratotomy), and soon, LASIK
(laser-assisted in-situ keratomileusis) for correction of nearsighted
ness, astigmatism, and corneal scarring.
Oculoplastic and Reconstructive Surgery
Vernon Jim, who retired in 1992 was board-certified in both
plastic surgery and ophthalmology, pioneered this field. Jorge
Camara arrived in Hawaii in 1982 after a fellowship at Baylor
College of Medicine in oculoplastic and reconstructive surgery.
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Scott Kortvelesy trained in neuroophthalmology has made contri
butions in orbital surgery. Carl Minatoya and Steven Sameshima
have distinguished themselves in ophthalmic plastic surgery.
Retinopathy of Prematurity
One of the first cases of retrolental fibroplasia was documented in
Hawaii in late 1941. In 1942. T.L. Terry of Boston” reported cases
of premature infants with gray-white opacities behind their lenses.
The incidence of retrolental membranes increased alarmingly. In
1950, Gordon of Colorado suggested the high concentration of
oxygen given the infants as the cause. In 1977, retinopathy of
prematurity was reported in 50 percent of infants weighing less than
1500 grams. This incidence has been reduced dramatically by
careful monitoring of oxygen concentration in infant incubators.
Xenon Arc Photo Coagulator, Cryosurgical, and
Lasers
Diathermy was formerly used to produce chorioretinal adhesions
around retinal breaks. In 1946 Meyer-Schwickerath began experi
menting with sunlight as the energy source to produce chorioretinal
burns. A commercial photocoagulator was subsequently developed
which produced light radiation by passing electrical current through
gas. This instrument, the Xenon Arc Photocoagulator, was the
highlight of the International Congress of Ophthalmology exhibit in
Brussels in 1958. In 1965 Harry Cooke donated this equipment to
St. Francis Hospital where it was used extensively by Drs Herbert
Pang and Frissell for retinal detachments and at least on one case of
bilateral retinoblastoma with excellent results.
Cryosurgical units operate on the Joule-Thompson principle that
temperature drops when pressurized gas is forced through a narrow
aperture. Cryosurgery was first used for cataract extraction in 1965
by Sugiki. It is the preferred instrumentation for retinal breaks and
intraocular tumors.
Light amplification by simulated emission of radiation (laser)
was first described in 1960. Investigations into laser light iridecto
mies were begun immediately. The first laser available, the pulsed
ruby, failed in iridectomies. Improvements in performance started
an investigative furor in the mid-1970s. The success of these
investigations has made the argon laser iridectomy the procedure of
choice.
Argon laser first became available in 1980. Argon laser photoco
agulation has a high degree of effectiveness and applicability. It is
the current treatment for certain stages of diabetic retinopathy. It is
used for laser trabeculoplasty. It is the preferred method of prophy
laxis for lattice degeneration, cystic retinal tufts, degenerative
retinoschisis, and retinal breaks. In many cases, of retinal breaks
transconjunctival cryotherapy for retinal breaks is preferred, espe
cially for eyes with cloudy media.
Use of the Neodymium YAG laser (neodymium yttrrium-alumi
num-garnet) is classified as photodisruptive surgery. It was devel
oped in 1984 and became available in Hawaii the same year. The
most widespread application of this laser technology is in section
ing the posterior capsule of the aphakic eye.
Conclusion
Ophthalmology has been transformed into a specialty of supreme
sophistication. The metamorphosis from the ancient surgical art of
cataract couching to a precise and skilled discipline has been driven
by the revolution in instrumentation and technology. Hawaii is
fortunate to have benefited from a constant and unrelenting flow of
ophthalmologists who have been trained in the most current tech
niques and their contributions to health care in Hawaii is simply
outstanding.
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Editorial
Continuedfrom Page 224
• 1994 - Dr Robert Michael Blaese, Deputy Chief, Metabo
lism
• 1995 - Flossie Wong-Staal, PhD, Florence Riford Chair in
AIDS Research, Professor ofMedicine & Biology, University
of California, San Diego.
The Blue Ribbon Panel on Living and
Dying with Dignity
The Governor’s Blue Ribbon Panel on Living and Dying
with Dignity has been meeting since January, and plans to hold
public hearings around the State in October to hear from
Hawaii residents. The 18-member panel has been studying
more than just physician-assisted death, and has looked at
issues of pain management and palliative care, financial costs
of dying, hospice, legal concerns including whether advance
directives are being followed, spiritual and religious aspects,
cultural differences and perspectives from various special
interest groups. After the public hearings, the panel will
develop policy and program recommendations. Prior to pre
senting these recommendations to the Governor, the panel will
hold additional public hearings.
The panel has just published its first newsletter, and persons
wanting to be included on the mailing list for that newsletter
should contact the Executive Office on Aging at 586-0100.
The specific dates and times for the public hearings will be
soon available.
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